[go: up one dir, main page]

Malinowska et al., 2009 - Google Patents

Polymorphism of genes encoding homocysteine metabolism–related enzymes and risk for cardiovascular disease

Malinowska et al., 2009

Document ID
17778283476762315188
Author
Malinowska A
Chmurzynska A
Publication year
Publication venue
Nutrition Research

External Links

Snippet

The aim of this review is to present a general overview of the relationships among homocysteine metabolism, polymorphism of the genes encoding homocysteine metabolism– related enzymes, and the nutrients influencing the plasma homocysteine level. Combining …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl group being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Malinowska et al. Polymorphism of genes encoding homocysteine metabolism–related enzymes and risk for cardiovascular disease
Coppen et al. Treatment of depression: time to consider folic acid and vitamin B12
Cattaneo Hyperhomocysteinemia and venous thromboembolism
Fowler Disorders of homocysteine metabolism
Bailey et al. Folate metabolism and requirements
Townsend et al. Sulfur containing amino acids and human disease
Lawson-Yuen et al. The use of betaine in the treatment of elevated homocysteine
Dayal et al. ADMA and hyperhomocysteinemia
Belcastro et al. Antiepileptic drugs, hyperhomocysteinemia and B-vitamins supplementation in patients with epilepsy
AU2002250942B2 (en) Compositions of biochemical compounds involved in bioenergy metabolism of cells
McKinley Nutritional aspects and possible pathological mechanisms of hyperhomocysteinaemia: an independent risk factor for vascular disease
van der Griend et al. Hyperhomocysteinaemia as a cardiovascular risk factor: an update
WO2018053605A1 (en) Diagnosis, prognosis and treatment for schizophrenia and schizoaffective psychosis
Hendriksz et al. Update on phenylketonuria
Fryar-Williams Fundamental role of methylenetetrahydrofolate reductase 677 C→ T genotype and flavin compounds in biochemical phenotypes for schizophrenia and schizoaffective psychosis
Sunder-Plassmann et al. Genetic determinants of the homocysteine level
RS65577B1 (en) Dietary supplementation to achieve oxy-redox homeostasis and epigenetic stability
Bakker et al. Hyperhomocysteinaemia and associated disease.
Lutz Alterations in homocysteine metabolism among alcohol dependent patients-clinical, pathobiochemical and genetic aspects
Martin B12 and folate deficiency dementia
Halsted The intestinal absorption of dietary folates in health and disease.
CA2876169C (en) Methods of preventing or treating disease states related to certain metabolic abnormalities
Fukagawa et al. Advancing age and other factors influencing the balance between amino acid requirements and toxicity
Brosnan et al. Amino acids and the regulation of methyl balance in humans
Kvittingen et al. Methionine synthase deficiency without megaloblastic anaemia